# UCB S.A.: Form D filing

UCB S.A., a pharmaceuticals company in Smyrna, GA, filed a Form D with the SEC in 2015. The latest, on May 13, 2015, reports $787,628 sold of a $787,628 offering to 131 investors.

Find out what UCB S.A. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20UCB%20S.A.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=UCB%20S.A.&page=%2Fdata%2Fform-d%2Fcompany%2Fucb-s-a-1290640)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20UCB%20S.A.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=UCB%20S.A.&page=%2Fdata%2Fform-d%2Fcompany%2Fucb-s-a-1290640)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Georgia](https://specstream.ai/data/form-d/state/georgia): 1,337 rows, by operating companies, filed since November 1, 2024, $66.85, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/georgia
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: C/O UCB, INC., 1950 LAKE PARK DRIVE, Smyrna, GA, 30080
- Phone: (770) 970-7500
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Belgium
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1290640

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 13, 2015 | New notice | $787,628 | $787,628 | $0 | 131 | Apr 8, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1290640/000129064015000004/0001290640-15-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Cedric van Rijckevorsel | Director |  |
| Charles-Antoine Janssen | Director |  |
| Norman Orstein | Director |  |
| Arnoud de Pret | Director |  |
| Jean-Pierre Kinet | Director |  |
| Gerhard Mayr | Executive Officer, Director |  |
| Michel Xavier | Executive Officer |  |
| Albrecht De Graeve | Director |  |
| Jean-Christophe Tellier | Executive Officer, Director |  |
| Evelyn du Monceau | Director |  |
| Kay Davies | Director |  |
| Jeffrey Wren | Executive Officer |  |
| Ctesse du Monceau de Bergendal | Executive Officer |  |
| Tom McKillop | Director |  |
| Harriet Edelman | Director |  |

## Other pharmaceuticals companies in Georgia that filed recently

- [Laurentide Therapeutics Inc.](https://specstream.ai/data/form-d/company/laurentide-therapeutics-inc-2157396) $99,999 · Sep 28, 2026
- [LifeCyte Innovations, Inc.](https://specstream.ai/data/form-d/company/lifecyte-innovations-inc-2150601) $1 million · Aug 20, 2026

[Every Form D from the week of May 11, 2015](https://specstream.ai/data/form-d/week/2015-05-11) · [All recent filings in Georgia](https://specstream.ai/data/form-d/state/georgia) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what UCB S.A. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).